Company Filing History:
Years Active: 2001-2014
Title: John Swindle: Innovator in PKC Inhibition
Introduction
John Swindle is a notable inventor based in Seattle, WA (US), recognized for his contributions to the field of pharmacology. He holds 4 patents that focus on innovative methods for inhibiting specific protein kinases, which play a crucial role in various cellular processes.
Latest Patents
Swindle's latest patents include groundbreaking work on compounds and methods for PKCθ inhibition. The present invention provides a method of selectively inhibiting PKCθ in the presence of PKCδ by administering a therapeutically effective amount of a compound of Formula I to a subject in need. This invention also outlines methods for inhibiting cytokine synthesis in T cells, T cell proliferation, and the replication of T lymphocytes, while ensuring that B lymphocyte replication remains unaffected.
Career Highlights
Throughout his career, John Swindle has worked with several companies, including Complegen, Inc. and Complegen Partners, Inc. His work has significantly advanced the understanding of protein kinase inhibition and its therapeutic applications.
Collaborations
Some of his notable coworkers include Dean Dawson and Janet Ajioka, who have contributed to his research endeavors.
Conclusion
John Swindle's innovative work in PKC inhibition showcases his commitment to advancing medical science through his inventions. His contributions continue to impact the field positively.